Effect of Natalizumab on Circulating CD4(+) T-Cells in Multiple Sclerosis

Por Börnsen, Lars, Christensen, Jeppe Romme, Ratzer, Rikke, Oturai, Annette Bang, Sørensen, Per Soelberg, Søndergaard, Helle Bach, Sellebjerg, Finn
Publicado em 2012

Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression

Por Christensen, Jeppe Romme, Börnsen, Lars, Ratzer, Rikke, Piehl, Fredrik, Khademi, Mohsen, Olsson, Tomas, Sørensen, Per Soelberg, Sellebjerg, Finn
Publicado em 2013

Absence of systemic oxidative stress and increased CSF prostaglandin F(2α) in progressive MS

Por Lam, Magda A., Maghzal, Ghassan J., Khademi, Mohsen, Piehl, Fredik, Ratzer, Rikke, Romme Christensen, Jeppe, Sellebjerg, Finn Thorup, Olsson, Tomas, Stocker, Roland
Publicado no Neurol Neuroimmunol Neuroinflamm (2016)

Endogenous Interferon-β-Inducible Gene Expression and Interferon-β-Treatment Are Associated with Reduced T Cell Responses to Myelin Basic Protein in Multiple Sclerosis

Por Börnsen, Lars, Romme Christensen, Jeppe, Ratzer, Rikke, Hedegaard, Chris, Søndergaard, Helle B., Krakauer, Martin, Hesse, Dan, Nielsen, Claus H., Sorensen, Per S., Sellebjerg, Finn
Publicado no PLoS One (2015)